Literature DB >> 16513181

EHV-1 and EHV-4 infection in vaccinated mares and their foals.

C E Foote1, D N Love, J R Gilkerson, J E Wellington, J M Whalley.   

Abstract

A silent cycle of equine herpesvirus 1 infection was described following epidemiological studies of unvaccinated mares and foals on a Hunter Valley stud farm. Following the introduction of routine vaccination with an inactivated whole virus equine herpesvirus 1 (EHV-1) and equine herpesvirus 4 (EHV-4) vaccine in 1997, a subsequent study identified excretion of EHV-1 and EHV-4 in nasal swab samples tested by PCR from vaccinated mares and their unweaned, unvaccinated foals. The current sero-epidemiological investigation of vaccinated mares and their young foals found serological evidence of EHV-1 and EHV-4 infection in mares and foals in the first 5 weeks of life. The results further support that EHV-1 and EHV-4 circulate in vaccinated populations of mares and their unweaned foals and confirms the continuation of the cycle of EHV-1 and EHV-4 infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513181     DOI: 10.1016/j.vetimm.2006.01.007

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  6 in total

1.  Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): infection with Equine Herpesvirus-1.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Helen Clare Roberts; Barbara Padalino; Paolo Pasquali; Hans Spoolder; Karl Ståhl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Andrea Carvelli; Romain Paillot; Alessandro Broglia; Lisa Kohnle; Francesca Baldinelli; Yves Van der Stede
Journal:  EFSA J       Date:  2022-01-12

2.  Successful control of winter pyrexias caused by equine herpesvirus type 1 in Japanese training centers by achieving high vaccination coverage.

Authors:  Hiroshi Bannai; Naomi Mae; Hirotaka Ode; Manabu Nemoto; Koji Tsujimura; Takashi Yamanaka; Takashi Kondo; Tomio Matsumura
Journal:  Clin Vaccine Immunol       Date:  2014-05-28

3.  Application of equine herpesvirus-1 vaccine inactivated by both formaldehyde and binary ethylenimine in equine.

Authors:  Fatma F Warda; Hala El Sawy Ahmed; Nermeen G Shafik; Christine A Mikhael; Heba M G Abd-ElAziz; Walaa A Mohammed; Eman A Shosha
Journal:  Vet World       Date:  2021-07-15

4.  Frequency of Detection and Prevalence Factors Associated with Common Respiratory Pathogens in Equids with Acute Onset of Fever and/or Respiratory Signs (2008-2021).

Authors:  Nicola Pusterla; Kaitlyn James; Samantha Barnum; Fairfield Bain; D Craig Barnett; Duane Chappell; Earl Gaughan; Bryant Craig; Chrissie Schneider; Wendy Vaala
Journal:  Pathogens       Date:  2022-07-02

5.  Equid herpesvirus 1 and rhodococcus equi coinfection in a foal with bronchointerstitial pneumonia.

Authors:  Alejandro Perez-Ecija; Francisco Javier Mendoza; José Carlos Estepa; María José Bautista; José Pérez
Journal:  J Vet Med Sci       Date:  2016-06-03       Impact factor: 1.267

6.  An Outbreak of Equine Herpesvirus-4 in an Ecological Donkey Milk Farm in Romania.

Authors:  Alexandra Mureşan; Cosmin Mureşan; Madalina Siteavu; Electra Avram; Diana Bochynska; Marian Taulescu
Journal:  Vaccines (Basel)       Date:  2022-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.